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Large unilamellar vesiclesThe function of diphtheria toxin translocation (T) domain is to transfer the catalytic domain across the endosomal
membrane upon acidiﬁcation. The goal of this study was to develop and apply an in vitro functional assay for T
domain activity, suitable for investigation of structure–function relationships of translocation across lipid bilayers
of various compositions. Traditionally, T domain activity in vitro is estimated bymeasuring either conductance in
planar lipid bilayers or the release of ﬂuorescent markers from lipid vesicles. While an in vivo cell death assay is
the most relevant to physiological function, it cannot be applied to studying the effects of pH or membrane lipid
composition on translocation. Here we suggest an assay based on cleavage of the N-terminal part of T domain
upon translocation into protease-loaded vesicles. A series of control experiment was used to conﬁrm that
cleavage occurs inside the vesicle and not as the result of vesicle disruption. Translocation of the N-terminus of
the T domain is shown to require the presence of a critical fraction of anionic lipids, which is consistent with
our previous biophysical measurements of insertion. Application of the proposed assay to a series of T domain
mutants correlated well with the results of cytotoxicity assay.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Diphtheria toxin consists of three covalently linked domains: recep-
tor, translocation and catalytic. After the receptor domain binds to the
EGFR-like receptor on the cell surface, the toxin is endocytosed into
the cell. The subsequent acidiﬁcation of the endosome induces refolding
andmembrane insertion of the translocation (T) domain and transloca-
tion of the catalytic domain into the cytosol. The translocated catalytic
domain is cleaved off of the T domain at furin site (RVRR, position
190–193) and acts as an inhibitor of EF1 translation factor, leading to
termination of protein synthesis and cell death [1,2]. Certain mutations
in T domain are known to cause partial or complete loss of its activity,
thus producing nontoxic protein species [3,4]. The cell death assay is
commonly used to determine the activity of the full-length toxin,
where decrease in incorporation of radioactive amino acids into the
acid-insoluble fraction reﬂects cell death after toxin administration.
This method is an ultimate assay for determination of T domain species
activity but requires a live cell culture and radioactive isotopes [5,6]. The
isolated T domain (residues 202–378) is known to form pores in the ar-
tiﬁcial membranes and to translocate its N-terminus across the bilayer
in response to acidiﬁcation. This pore formation can be utilized to
study the effects ofmutations and the inﬂuence ofmembrane lipid com-
position on the T domain activity in vitro [7,8]. The following two
methods are used to study the properties of isolated T domain: leakage1 913 588 7440.assay, in which activity is estimated by the release of ﬂuorescent dye
from the vesicles [9], and electrophysiological assay, in which the in-
crease of conductance due to pore formation by T domain is measured
[10]. Although both methods are relatively simple and reproducible,
several studies have demonstrated that their results are not always con-
sistentwith those of cell death assay [5]. Therefore there is a need to de-
velop a newmethod for T domain activity assaywhere the translocation
of the N-terminal protein portion across themembrane can be observed
directly.
It has been suggested that upon channel formation by the T domain,
its N-terminus crosses the lipid bilayer. Also, the inhibition of rapid
channel closure by trans trypsin, combinedwithmutagenesis to localize
the trypsin site, indicated that some portion of the 63-amino acid N-
terminal segment of the T domain was translocated to the trans side of
the membrane [8]. Here, we follow up on these ﬁndings to establish a
proteolysis-based assay, where, upon translocation of T domain N-
terminus across the lipid bilayer, the link between N-terminal His-tag
and T domain body is cleaved at a speciﬁc site (PRG) by thrombin locat-
ed on the trans side of the membrane (inside the vesicles).
Proteases are widely used to study membrane protein structure via
two general approaches: (I) external protease addition,where potential
proteolysis sites are protected by the membrane after incorporation of
the protein into it, and (II) internal proteolysis, where protease-loaded
LUV are used and the parts of the protein expanded into themembrane
become accessible for proteolysis [11]. In some cases, artiﬁcial tags for
protease cleavage were inserted into the protein sequence at locations
of interest in order to study the accessibility of certain parts of the
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determination of the activity of the isolated T domain, based on the
proteolytic cleavage of the N-terminal His-tag translocated into lipid
vesicles. The T domain was cloned into pET15b vector, which contained
the following features: 18 amino acid N-terminal His-tag and a
thrombin cleavage site, located 3 amino acids upstream from the begin-
ning of canonical T domain sequence.Wedemonstrate that the cleavage
of the His-tag in the course of T domain interaction with thrombin-
loaded vesicles occurs only when the N-terminal part had been
translocated across the bilayer into the vesicle. We applied this method
to studying dependence of LUV translocation efﬁciency on lipid compo-
sition of the artiﬁcialmembrane; the results conﬁrm our previous state-
ment that a high content of acidic phospholipids is important for the
formation of the ﬁnal inserted state [15].We have also studied the activ-
ity of several T domain mutants carrying replacements of certain histi-
dine residues with neutral or positively charged ones, and results
obtained are in good agreement with cell death assay data.
2. Materials and methods
2.1. Materials
Palmitoyloleoylphosphatidylcholine (POPC), palmitoyloleoylphosphatidyl-
gycerol (POPG), andpalmitoyloleoylphosphatidylserine (POPS)were ob-
tained from Avanti Polar Lipids (Alabaster, AL). Bovine thrombin was
from Fisher Scientiﬁc (Pittsburgh, PA). The CLY3 construct containing
the fusion of enhanced cyan and enhanced yellow ﬂuorescent proteins
was provided by Addgene (Cambridge, MA)[16]. Themutations were in-
troduced using Site-Directed Mutagenesis Kit (Stratagene, Santa Clara,
CA) according to manufacturer's protocol. 8-aminonaphtalene-1,3,6-
trisulfonic acid, disodium salt (ANTS) and p-xylene-bis-pyridinium bro-
mide (DPX) were obtained from Molecular Probes (Eugene, OR).
2.2. Preparation of T domain
Diphtheria toxin T domain (segment 202–378 of the full-length
toxin) was prepared as described in [2]. Brieﬂy, BL23DELysS cells trans-
formed with pET15b plasmid containing T domain gene were grown to
OD600 = 0.6, induced with 0.8 mM IPTG and grown overnight at 24 °C.
After harvesting, cells were lysed by soniﬁcation, cell debris spun down
and soluble T domain was bound to Ni-NTA (Qiagen, MA). After several
washes the protein was eluted from the resin with 0.5 M imidazole in
the binding buffer and additionally puriﬁed by size-exclusion FPLC on
a Superose 12 column in 50 mM sodium-phosphate buffer, pH 8. T
domain-containing fractions were stored at−80 °C until use.
2.3. Vesicle permeabilization (leakage) assay
LUV with entrapped ANTS and DPX were prepared as previously
described [9,17]. Brieﬂy, lipids from chloroform stocks were mixed in
desired proportions and dried overnight, resuspended in 50 mM phos-
phate buffer, pH 8 containing 1 mM of ANTS and 10 mM of DPX. The
lipid solutions were then frozen and thawed 10 times followed by ex-
trusion. Lipid solutions were prepared at 20 mM concentration.
Separation of the untrapped solutes was achieved by size exclusion
chromatography on the Sepharose 6 column 1× 30 cm, in 50mMphos-
phate buffer pH 8, ﬂow rate 0.25 mL/min. The fraction of LUV was elut-
ed at the free volume of the column (retention 6 mL). The release of
markers was assayed ﬂuriometrically using a SPEX Flurolog FL 3-22
steady state ﬂuorescence spectrometer (Jobin Yvon, Edison, NJ)
equipped with double grating excitation and emission monochroma-
tors. ANTS ﬂuorescence was excited at 353 nm and measured at
520 nm wavelength. The concentration of the T domain WT and mu-
tants was 0.2 μM, and the concentration of LUVwas 0.2mM in the sam-
ple total volume of 0.4 mL. The reaction was initiated by decrease of pH
to 5.5 by addition of an aliquot of 2.5 M sodium acetic buffer. Thekinetics of T domain-induced dye release were measured until ANTS
ﬂuorescence reached the plateau, normally after 1 h of incubation. In
order to determine the level of ANTS ﬂuorescence after complete re-
lease of LUV content, the vesicles were completely dissolved by addition
of 10 μl of 25% Triton X-100.
2.4. Preparation of thrombin-loaded LUV
Phospholipid mixtures with desired compositions from chloroform
stocks were dried overnight and suspended in 50 mM sodium-
phosphate buffer, pH 8, in the ﬁnal concentration of 20 mM, with
addition of 100 U thrombin per mL. After 5 cycles of freezing in liquid
nitrogen/thawing, followed by extrusion through 100 nm ﬁlter
(Whatman, PA), LUV were stored overnight at 4 °C and subjected to
FPLC on a Superose 6 column to remove non-trapped thrombin (we
typically repeated this procedure 2–3 times, at the low elution rate of
0.25 mL/min, which appeared key to preserving LUV integrity). To con-
ﬁrm the absence of untrapped thrombin we incubated the mixture of
LUV with T domain or CLY3 (0.1 μM of both proteins and 0.1 mM of
lipid) at pH 8 for 1 h at room temperature. If we did not observe cleav-
age of T domain, the batch was considered suitable for activity
determination.
2.5. Translocation assay
Wild type (WT) ormutant T domainwasmixedwith LUV in the vol-
ume 50 μL in 50 mM sodium-phosphate buffer pH 8 at room tempera-
ture. The ﬁnal concentrations were: 0.1 μM of protein and 0.1 mM of
lipid. The samples were incubated for 10 min after which pH was ad-
justed to the desired level by the addition of appropriate amounts of
2.5 M sodium acetate buffer, pH 4. After 1 hour incubation at desired
pH, the reaction was stopped by addition of Laemmli sample buffer
and boiling, the results of proteolysis were analyzed by SDS-
polyacrylamide gel electrophoresis in 4–20%gels andquantiﬁed by den-
sitometry usingMolecular Imager Gel Doc XR+ image system (BioRad,
CA). Each experiment was repeated in triplicate. The degree of translo-
cation is calculated as a fraction of cleaved T domain (−His-tag band on
SDS-PAGE) of the total T domain (−His-tag and +His-tag bands on
SDS-PAGE).
2.6. Control experiment
The objective for the control experiment was to determine that
cleavage of His-tag was achieved via N-terminus translocation but not
by acidiﬁcation or membrane disruption caused by T domain. We pre-
pared the mutant of CLY3 dimer of ﬂuorescent proteins described in
[16], where Ile was mutated to Pro in the linker between cyan and yel-
low ﬂuorescent proteins, thus creating the site for thrombin cleavage
(sequence IRG to PRG, cleavage occurring between R and G). This con-
struct was incubated with thrombin-loaded LUV (0.1 mM) at pH 8
and 5.6, in a ﬁnal concentration of 100 nM in the presence and absence
of T domain, for 1 h at room temperature. The cleavage was examined
using SDS-polyacrylamide gel.
3. Results
The principal scheme of the translocation assay is shown in Fig. 1. T
domain was added to thrombin-loaded vesicles at pH 8, and after short
co-incubation pHwas adjusted to the desired level. Under acidic condi-
tions T domain was bound to the membranes and translocated its N-
terminal part across the lipid bilayer. When His-tag was inserted into
the vesicle, the thrombin site RG (indicated by arrow) becomes accessi-
ble to the protease and the 18-residue N-terminal segment is cleaved.
The cleaved and uncleaved forms have sufﬁciently different electropho-
retic mobility to be distinguished on SDS-polyacrylamide gels (Fig. 1).
Fig. 1. Schematic representation of the functional assay of diphtheria toxin T domain based on the cleavage of the translocated N-terminal segment. T domain is presented by two
rectangles (top left), with the open one representing the bulk of the structure, and solid one representing cleavable N-terminus. Cleave site is identiﬁed on the sequence (top center),
while cleaved (−His-tag,MW19.7 KDa) and uncleaved T domain (+His-tag,MW21.6 KDa) can be distinguished by SDS-PAGE (top right). When T domain is mixed with lipid vesicles,
pre-loadedwith thrombin, at neutral pH (bottom left), no translocation occurs and no cleavage is observed (only+His-tag species is detected by SDS-PAGE). Membrane insertion of the T
domain, triggered by acidic pH, results in the translocation of its N-terminus across the bilayer (bottom right), which exposes the thrombin cleavage site to the thrombin and results in
cleavage of the His-tag (increase in−His-tag species at decreasing pH values is detected by SDS-PAGE). A series of specially designed control experiments (see Fig. 2 and text) conﬁrms
that the cleavage occurs indeed inside the vesicle.
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conditions relevant to translocation conditions, we ﬁrst examined the
pH dependence of cleavage without LUV. The results show that in the
pH range between 8 and 5.6, the protease exhibited 100% activity
against T domain. The thrombin activity, however, was reduced strongly
below pH 5.5, and no cleavage was observed at pH 5 (see Supplemental
Materials). Thus, the working pH range was sufﬁcient for application of
thrombin to studies of diphtheria toxin.
Next we explored the effect of LUV composition on translocation in
the membranes consisting of the mixtures of neutral (POPC) and acidic
(POPG or POPS) phospholipids. The quality of the thrombin-loaded
vesicles appears to be a key factor in translocation assay. The most
important aspect of vesicle preparation was removal of external throm-
bin from the samples. We have checked different columns for size-
exclusion chromatography in our initial attempts and obtained the
best results using a Superose 6 1 × 30 cm column,where LUVwere elut-
ed in the free volume while untrapped thrombin was retained on the
column (elution at 8 and 12 mL, respectively). Despite good peak reso-
lution, we have found that some LUV samples prepared this way still
contained considerable amounts of untrapped thrombin. To eliminate
this problem, we subjected the preparations to additional gel ﬁltration
steps through the same column under the same conditions (50 mM
Na-phosphate buffer, pH 8, ﬂow rate 0.25 mL/min). The vesicles
remained intact at a ﬂow rate of 0.25 mL/min or less, while higher
ﬂow rates caused apparent vesicle disruption, as evidenced by the al-
tered elution proﬁles showing the reduction in peak corresponding to
LUV. The thrombin loaded into LUV remained active for at least
2 weeks when stored at 4 °C.
Fig. 2 shows the control experiment in which we checked whether
acidiﬁcation of environment itself or acid-induced pore formation by T
domain could cause the release of protease from the vesicles. For
these experiments we used a protein chimera construct—a fusion of
eCFP and eYFP ﬂuorescent proteins (CLY3) connected through ﬂexible
linker [16]. In order to introduce thrombin site we substituted original
Ile in the linker with Pro: Pro-Arg-Gly. The experiments in solution
have shown that this construct was readily cleaved by thrombin in all
the ranges of pH suitable for the translocation assay.We did not observe
the cleavage of the construct at either pH 8 or at pH 5.6 in the presenceof thrombin-loaded LUV (75% POPG:25% POPC). The addition of
T domain and its acid-induced insertion did not cause the digestion of
the control CLY3 protein mutant (concentration of either protein was
100 nM), conﬁrming that thrombin is not released from the vesicles
under T domain insertion conditions.
Wemeasured the translocation activity of T domainWT at pH 8, 7.2,
6.4, and 5.6 in membranes with a high content of acidic phospholipid
POPG (75%), which are known to be optimal for T domain insertion
[18]. The results show a monotonic increase of the cleaved (−His-tag)
T domain form in the course of pH decrease (Fig. 1, top right panel),
which is consistent with acid-driven insertion and translocation. Next,
we characterized the dependence of translocation at pH 5.6 on the frac-
tion of anionic lipids in the bilayer. Translocation was decreased with
the lower acidic phospholipid content, and at POPG content below
15% it was practically undetectable (Fig. 3, squares). Similar threshold
dependence was observed for POPS with virtually no activity observed
below20% of anionic lipid (triangles). In contrast, no threshold behavior
is seen for the leakage activity of the T domain, measured by ﬂuores-
cence changes associated with the release of dye-quencher pair ANTS/
DPX (circles).
We have also studied the translocation activity of the following T do-
main mutants: two single mutants, H257R andH257Q, and two triple
mutants, H322R/H323R/H372R (3H-to-R) and H322Q/H323Q/H372Q
(3H-to-Q). Previously we have examined the biophysical properties of
these mutants [5,15]. Data in Fig. 4A show the results of a translocation
assay in highly acidic LUV (75%POPG:25%POPC). In these experiments
the levels of activity for both H257R and H257Q mutants were compa-
rable to those of WT T domain, while both triple mutants (especially
3H-to-R) showed signiﬁcantly reduced levels of activity at pH 5.6.
These data conﬁrm the important role of the group of three C-
terminal histidines for T domain translocation, supporting the results
we obtained earlier using the set of biophysicalmethods [5]. The activity
of both triple mutants was almost undetectable when translocation
assay was performed using LUV with the lower content of acidic phos-
pholipids (25%POPG:75%POPC). In contrast, WT and H257 mutants,
whenmeasured with 25% POPG, preservedmore than half of transloca-
tion activity relative to that observed with 75% POPG membranes (data
not shown).
Fig. 2. Summary of control experiment conﬁrming that the cleavage by thrombin does not
occur as a result of release of thrombin from the vesicles. These experiments utilize a
model protein CLY3 (MW 57 KDa), consisting of two ﬂuorescent proteins connected by
a ﬂexible linker into which a site cleavable by thrombin is introduced. Cleavage of this
construct into two monomers (MW 28 KDa each) can easily be detected by SDS-PAGE at
either neutral or mildly acidic pH (lanes 1–3) and the experiments can be repeated either
in the absence or presence of vesicles or T domain. No cleavage of CLY3 is detected in the
presence of vesicles pre-loaded with thrombin (lanes 4, 5), nor when T domain is added
(lines 6, 7). While the T domain inserted at pH 5.6 is cleaved (line 7), the CLY3-dimer,
residing outside of the vesicles, is not. This conﬁrms that under conditions of our assay
the cleavage occurs only inside the vesicles, and therefore truly represents the
translocation of T domain's N-terminus.
Fig. 3. Lipid-dependent translocation activity of the T domain (solid symbols) is compared
to its membrane permeabilization activity, measured in ﬂuorescent dye ANTS and its
quencher DPX leakage assay (open symbols). For better visualization, both translocation
and leakage activity data are normalized to the corresponding activity value observed in
75%POPG:25%POPC LUV. The levels of leakage in the vesicles with different composition
were determined after 1 h of incubation at pH 5.5 (the details of leakage and translocation
experiments are provided in Materials and methods section.) The translocation activity
observed in both POPG-containing (red squares) and POPS-containing vesicles (blue
triangles) exhibits a clear threshold effect. No activity is observed at low content of anionic
lipids, which correlates with our published observation that T-domain at such conditions
populates a non-active interfacial intermediate state [18]. In contrast, leakage data show
no such threshold dependence, suggesting that membrane disruption allowing for the
leakage of small markers is caused by the transient bilayer perturbation, due to interfacial
binding, and not translocation.
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with those of the cell death assay (Fig. 4B), reproduced from our previ-
ous publications [5,15]. The cell death assay is performed using a weak-
ened strain of the full-length protein and is based on monitoring the
inhibition of protein synthesis [6]. Reduction in cell death activity is
reﬂected in an increased concentration of the T domain, necessary to
achieve a particular reduction in protein synthesis. The intercepts of
the activity curves with the dotted line, corresponding to a 50% activity
level, are highlighted in Fig. 4B and indicate the following rank order of
activity: WT = H257R = H257Q N 3H-to-Q N 3H-to-R. This is exactly
the rank order observed in our translocation experiments at pH 5.6
(highlighted in Fig. 4A). In contrast, leakage-based assay (Fig. 4C)
shows no correlation with either cell death or translocation data.
The time traces corresponding to changes in ﬂuorescence dye
ANTS, co-entrapped with the quencher DPX into LUV containing
(75%POPG:25%POPC), caused by T domain-induced leakage of vesi-
cle content are shown in Fig. 4C. For all of the mutants, the changes
triggered by lowering the pH to 5.5 result in increased intensity
which reaches the same level as for the WT (albeit with different
rates). Note that under these conditions the release caused by T do-
main is not complete and complete disruption of LUV with Triton
causes further increase of ﬂuorescence intensity. Thus, all mutants
exhibit identical levels of ANTS/DPX release after 1 h of triggering
the insertion.4. Discussion
The goal of this study was to develop and test a simple functional
assay for membrane translocation achieved by the isolated T domain
of diphtheria toxin, which would be applicable for screening various
mutants aswell as lipid compositions. The need for such an assay is crit-
ical not only for deciphering the molecular mechanisms of bacterial in-
fection but also for developing T domain-based cellular delivery systems
with potential of targeting cancer cells [19–22]. The traditional func-
tional assays for the isolated T domain are based either on measure-
ments of conductance in artiﬁcial bilayers [10] or on measurements of
release of vesicular contents [9]. While the latter can be used to assay
various lipid compositions, it is rather indirect, and, as our published re-
sults indicate, non-speciﬁc [5].
Here we have developed a new method for determination of T do-
main activity, which speciﬁcally addresses the translocation of hydro-
philic N-terminal extension of the cloned T domain across the bilayer
of phospholipid vesicles. This functional assay appears to be no more
complicated than traditional methods used previously [2,4,5], and it ac-
commodates easy manipulation of the target membrane's lipid compo-
sition, as illustrated in Fig. 3. The results obtained for both POPG (red)
and POPS (blue) clearly indicate that a certain fraction of anionic lipids
is needed for translocation activity. This threshold behavior is consistent
with our previous biophysical observations, indicating that anionic
lipids decrease the energy barrier for the transmembrane insertion
transition and that the T domain is kinetically trapped in the interfacial
intermediate state at low anionic lipid content [15,18]. This intermedi-
ate state is not functionally relevant and lacks the transmembrane ori-
entation of the helices.
Markedly, the leakage of low molecular weight markers ANTS/DPX
caused by T domain interaction with the vesicles does not show a
threshold effect (Fig. 3) and exhibits a 40% activity in pure POPC LUV.
It is likely that the leakage is caused during the transient initial binding
event by the redistribution of themass between the leaﬂets due to lipid
ﬂip-ﬂop, and not by the formation of the stable pore. Therefore, while
leakage studies can be very useful for detecting initial membrane inter-
actions and for comparing various mutants and bilayer lipid composi-
tions [5,15], their results should always be veriﬁed with other more
Fig. 4.Comparison of the activity of the T domainWT and four of itsmutants determined by three independent assays: translocation assay (A) cell death assay (B) and ﬂuorimetric leakage
assay (C). The color coding of T domain mutants is as follows: WT, black; H257R, orange; H257Q, blue; H322R/H323R/H372R (3H-to-R), dark yellow; H322Q/H323Q/H372Q (3H-to-Q),
olive. An example of the raw SDS-PAGE data used in determination of the translocation activity is shown in panel D (only the limiting pH points are presented for each mutant.). Both
translocation and leakage assays were conducted in 75%POPG:25%POPC LUV. Cytotoxicity and leakage data for triple C-terminal histidine mutants 3H-to-R and 3H-to-Q are from [5].
The leakage data for H257R andH257Qmutants are from [15].WT T domain and allmutants presented here induced identically high levels of leakage of ANTS/DPX fromvesicles (compare
relativeﬂuorescence values at ~60minhighlightedonpanel C). In contrast, a cytotoxicity assay revealed a substantial loss of activity for 3H-to-Q, and especially for 3H-to-R, as compared to
the WT protein and the H257R/Q mutants (compare intersections with the dotted line corresponding to the 50% activity highlighted in panel B). The results of the translocation assay
demonstrate identical high levels of translocation for theWT andH257mutants,moderate translocation for 3H-to-Q and low translocation for 3H-to-R (comparedata at pH5.6 highlighted
in panel A). This pattern is consistent with the results of the cytotoxicity assay (see text for details).
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to histidine mutants of the T domain, does not demonstrate substantial
differences from the WT protein, except for slightly slowed kinetics in
the case of glutamine substitutions (Fig. 4, panel C). At the same time,
the cell death assay revealed the highly decreased activity of the triple
C-terminal mutants compared to the WT and H257R and H257Q mu-
tants (panel B). The results of our T domain translocation assay (panel
A) reveal low translocation capability of the triple mutants in model
membranes, which again correlates well with the results of the cell
death assay performedwith the entire toxin [5]. Consistently, our previ-
ous biophysical studies indicate that these mutants can bind mem-
branes and even insert a pair of the most hydrophobic helices TH8
and TH9 (and thus cause leakage), but they get trapped in this interme-
diate conformation and are unable to properly insert the rest of the pro-
tein [5].
The good correlation between the results of the cell death assay and
our data for T domain mutants suggests that the mutants able to trans-
locate His-tag in our assay are also capable of translocating the catalytic
domain under in vivo conditions. We conclude that our assay is physio-
logically relevant aswell as being suitable for investigation of transloca-
tion across the membranes of various lipid compositions by various
mutants of diphtheria toxin T domain, and potentially by other binary
toxins.
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